(Q39138948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Jiaoli Guo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Wenping Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hongliu Shi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Xinhua Xie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Laisheng Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hailin Tang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Minqing Wu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lu Yang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jie Gao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Peng Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Weidong Wei

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Xiaoming Xie

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

15 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

103-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11010-013-1723-6

3 March 2020

exact match

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

PARP inhibitors in cancer therapy: promise, progress, and puzzles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Multiple biological activities of curcumin: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Multitargeting by curcumin as revealed by molecular interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Apoptosis induced by emodin is associated with alterations of intracellular acidification and reactive oxygen species in EC-109 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Emodin suppresses lipopolysaccharide-induced pro-inflammatory responses and NF-κB activation by disrupting lipid rafts in CD14-negative endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Immunosuppressive effect of emodin, a free radical generator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Unravelling the complexity of metastasis - molecular understanding and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

miR-34a expression, cell cycle arrest and cell death of malignant mesothelioma cells upon treatment with radiation, docetaxel or combination treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

The impact of curcumin on breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

MicroRNA expression profiling of male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

BMI1 as a novel target for drug discovery in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1723-6

Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23771315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23771315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23771315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11010-013-1723-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23771315%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference